Visufarma
Private Company
Funding information not available
Overview
Visufarma is a commercial-stage ophthalmic company formed in 2016 from the combination of Italy's Visufarma SpA and the commercial activities of France's Nicox SA. The company markets an established portfolio of products for dry eye, glaucoma, eyelid hygiene, and retinal health supplements, positioning itself as a specialized player in the European eye care market. Its strategy centers on commercializing innovative products sourced globally, supported by a focus on customer service and professional education. Visufarma is a private company with ambitions to become a recognized partner of choice in eye health across Europe and beyond.
Technology Platform
Commercial platform focused on in-licensing, marketing, and distributing ophthalmic products (small molecules, devices, supplements) in Europe.
Opportunities
Risk Factors
Competitive Landscape
Visufarma competes in the crowded ophthalmology market against giants like Alcon, AbbVie (Allergan), and Novartis, as well as other specialty pharma companies. Its differentiation relies on a focused product portfolio, customer service, and agility in commercializing niche products for European eye care professionals.